Qi-Bing Xie Selected Research

Qi-Bing Xie Research Topics

Disease

4	Inflammation (Inflammations) 01/2017 - 11/2012
4	Rheumatoid Arthritis 01/2014 - 01/2009
3	Dermatomyositis (Dermatopolymyositis) 03/2018 - 05/2011
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2016 - 05/2011
2	Interstitial Lung Diseases (Interstitial Lung Disease) 03/2018 - 09/2013
2	Polymyositis 01/2017 - 09/2011
2	Connective Tissue Diseases (Connective Tissue Disease) 09/2013 - 05/2011
2	Myositis (Idiopathic Inflammatory Myopathies) 09/2013 - 09/2013
2	Arthritis (Polyarthritis) 11/2012 - 05/2011
1	Neurogenic Diabetes Insipidus (Central Diabetes Insipidus) 10/2020
1	Hypopituitarism (Sheehan's Syndrome) 10/2020
1	Ulcer 03/2019
1	Thyroiditis 03/2018
1	Neoplasms (Cancer) 03/2018
1	Mediastinal Emphysema (Pneumomediastinum) 03/2018
1	Amyopathic dermatomyositis 03/2018
1	Tuberous Sclerosis (Bourneville's Disease) 01/2017
1	Hypoxia (Hypoxemia) 01/2017
1	Autoimmune Diseases (Autoimmune Disease) 01/2017
1	Myalgia 01/2017
1	Chronic Disease (Chronic Diseases) 01/2017
1	Crohn Disease (Crohn's Disease) 12/2015
1	Knee Osteoarthritis 01/2015
1	Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome) 01/2014
1	Infections 09/2013
1	Pneumonia (Pneumonitis) 09/2013
1	Experimental Arthritis 11/2012
1	Heart Failure 09/2011
1	Sclerosis 05/2011
1	Mixed Connective Tissue Disease (MCTD) 05/2011
1	Systemic Scleroderma (Systemic Sclerosis) 05/2011
1	Tuberculosis (Tuberculoses) 01/2009
1	Pulmonary Tuberculosis 01/2009

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 03/2018 - 01/2017
2	Mechanistic Target of Rapamycin Complex 1IBA 01/2017 - 01/2017
2	Sirolimus (Rapamycin)FDA Link 01/2017 - 01/2017
2	EnzymesIBA 01/2017 - 05/2011
2	Phosphotransferases (Kinase)IBA 12/2016 - 09/2013
1	GlucocorticoidsIBA 10/2020
1	Hormones (Hormone)IBA 10/2020
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 03/2018
1	AlbuminsIBA 03/2018
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 03/2018
1	AntigensIBA 03/2018
1	LipidsIBA 01/2017
1	Mechanistic Target of Rapamycin Complex 2IBA 01/2017
1	palmitoleic acidIBA 01/2017
1	Interleukin-23 (Interleukin 23)IBA 12/2015
1	Diclofenac (SR 38)FDA LinkGeneric 01/2015
1	Leflunomide (Arava)FDA LinkGeneric 01/2014
1	Interleukin-6 (Interleukin 6)IBA 09/2013
1	Jo-1 antibodyIBA 09/2013
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 09/2013
1	AminoglycosidesIBA 09/2013
1	Transaminases (Aminotransferases)IBA 09/2013
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 09/2013
1	Anti-Bacterial Agents (Antibiotics)IBA 09/2013
1	AntibodiesIBA 09/2013
1	Antinuclear AntibodiesIBA 09/2013
1	C-Reactive ProteinIBA 09/2013
1	Cephalosporins (Cephalosporin Antibiotics)IBA 09/2013
1	CreatineIBA 09/2013
1	Ferritins (Ferritin)IBA 09/2013
1	FluoroquinolonesIBA 09/2013
1	artenimol (dihydroartemisinin)IBA 11/2012
1	CollagenIBA 11/2012
1	Creatine Kinase (Creatine Phosphokinase)IBA 09/2011
1	Brain Natriuretic Peptide (Natrecor)FDA Link 09/2011
1	Indicators and Reagents (Reagents)IBA 05/2011
1	ImmunosorbentsIBA 05/2011
1	Anti-Citrullinated Protein AntibodiesIBA 05/2011
1	cyclic citrullinated peptideIBA 05/2011
1	Isoniazid (Ftivazide)FDA LinkGeneric 01/2009
1	Methotrexate (Mexate)FDA LinkGeneric 01/2009

Therapy/Procedure

6	Therapeutics 10/2020 - 01/2009